Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LITE vs MRNA✓SelectedUSD · MRNALITE vs MRNA performance historyLatest closeAs of-8.48%11/16
Stock and ETF performance explorer

LITE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+507.1%
MRNA return
-8.0%
Excess return
+515.1%
Maximum drawdown
-66.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.5%-3.6%-4.9%-8.3%
7D-8.4%-20.0%+11.6%-7.3%
30D-33.7%-1.3%-32.5%-33.6%
3M-41.0%+240.0%-281.0%-47.6%
6M-43.8%+339.0%-382.7%-53.2%
YTD+48.1%+630.0%-581.8%+9.9%
1Y+135.2%+769.1%-633.9%+69.2%
3Y+1,147.4%+181.2%+966.2%+944.1%
5Y+507.1%-8.1%+515.2%+446.2%
All+507.1%-8.0%+515.1%+446.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling